By synthesizing insights from recent studies, this article seeks to provide a comprehensive understanding of GSK3β as a critical factor in CKD development, paving the way for innovative therapeutic strategies to enhance kidney health and improve patient outcomes. The gene discussed is GSK3B; the disease is chronic kidney disease.